Prostacare Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 3

Prostacare General Information

Description

Provider of water electrolysis services intended to treat benign prostatic hyperplasia. The company offers a transurethral DC ablation procedure that creates localized pH imbalances to cause tissue necrosis, providing healthcare providers with office-based treatment options that relieve urinary symptoms without general anesthesia or surgical side effects.

Contact Information

Website
www.prostacare.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Level 5, 56 Pitt Street
  • Sydney, New South Wales 2000
  • Australia
+61 (02)
Primary Industry
Therapeutic Devices
Vertical(s)
Life Sciences
Corporate Office
  • Level 5, 56 Pitt Street
  • Sydney, New South Wales 2000
  • Australia
+61 (02)

Prostacare Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prostacare Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prostacare‘s full profile, request access.

Request a free trial

Prostacare Patents

  • 38

    Total Documents Applications and Grants

  • Total Patents Families

  • 33

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Prostacare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2026902066-A0 Non-thermal ablation system and method of use Pending 12-Mar-2026
US-11224474-B2 System for managing high impedance changes in a non-thermal ablation system for bph Active 28-Feb-2018
US-20200022748-A1 System for managing high impedance changes in a non-thermal ablation system for bph Active 28-Feb-2018
WO-2019168949-A1 System for managing high impedance changes in a non-thermal ablation system for bph Inactive 28-Feb-2018
AU-2017904778-A0 An apparatus and a method for the treatment of a prostatic disease Inactive 27-Nov-2017
To view Prostacare’s complete patent history, request access »

Prostacare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prostacare Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Prostacare‘s full profile, request access.

Request a free trial

Prostacare FAQs

  • When was Prostacare founded?

    Prostacare was founded in 2014.

  • Where is Prostacare headquartered?

    Prostacare is headquartered in Sydney, Australia.

  • What is the size of Prostacare?

    Prostacare has 6 total employees.

  • What industry is Prostacare in?

    Prostacare’s primary industry is Therapeutic Devices.

  • Is Prostacare a private or public company?

    Prostacare is a Private company.

  • What is Prostacare’s current revenue?

    The current revenue for Prostacare is .

  • How much funding has Prostacare raised over time?

    Prostacare has raised $2M.

  • Who are Prostacare’s investors?

    Solyco Capital and Transocean Group have invested in Prostacare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process